Skip to content
Taurolidine
Taurolidine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
B: Blood and blood forming organ drugs
B05: Blood substitutes and perfusion solutions
B05C: Irrigating solutions, blood substitutes and perfusion
B05CA: Antiinfective irrigating solutions
B05CA05: Taurolidine
HCPCS
No data
Clinical
Clinical Trials
12 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Catheter-related infectionsD05549922
Renal dialysisD006435EFO_0010690Z99.2112
ThrombosisD01392711
Central venous cathetersD06290511
Home parenteral nutritionD01633111
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_000054422
SepsisD018805A41.9112
Chronic kidney failureD007676EFO_0003884N18.611
Parenteral nutritionD01028811
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Central nervous system neoplasmsD01654311
Ovarian neoplasmsD010051EFO_0003893C5611
Fallopian tube neoplasmsD00518511
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTAUROLIDINE
INNtaurolidine
Description
Taurolidine is a thiadiazinane.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1
Identifiers
PDB
CAS-ID19388-87-5
RxCUI
ChEMBL IDCHEMBL2105420
ChEBI ID
PubChem CID29566
DrugBankDB12473
UNII ID8OBZ1M4V3V (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 533 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
8 adverse events reported
View more details